MindCotine uses VR to help users stop smoking, launches a crowdfunding campaign

The program combines mindfulness practices, psychological therapies and community engagement to combat nicotine addiction.

Magellan Health, Click Therapeutics team-up to launch a mobile-enabled smoking cessation program

The all-in-one solution will combine Magellan's clinical coaching and pharmacy benefit management capabilities with Click's machine learning platform.

Smoking cessation app making it easier to order GSK nicotine patches

Under the deal, those using 2morrow's SmartQuit app as part of an employer program will be able to more easily get GSK's nicotine replacement therapy.
Chrono Therapeutics

Small trial demonstrates the effectiveness of Chrono Therapeutics’ smoking cessation tech

When compared to subjects treated with placebo, test subjects had a statistically significant and clinically meaningful reduction in cravings.
SmartQuit app

2Morrow’s smoking cessation app SmartQuit heading to Turkey

Together with mHealth Technologies, 2Morrow will localize the SmartQuit app to help about 14 million people in Turkey (as of 2013) kick the habit.
Chrono Therapeutics

Chrono Therapeutics receives second Fast Track SBIR grant from the NCI

The award of up to $2.3M will support final product development of the digital portion of Chrono's patient-individualized smoking cessation therapy.

This smart cigarette case wants to help smokers kick the habbit

Stemming from the Engineering Entrepreneurs Program at North Carolina State University, the project recently launched an Indiegogo crowdfunding campaign.

Rock Health backs Chrono Therapeutics’ smoking cessation wearable

The company makes the SmartStop device which is worn on the arm or body, and used as a drug (nicotine) delivery tool that works with a companion mobile app.
Kosmo eCigarette

Kosmo’s smart e-cigarette helps quit smoking

Set to ship in September, Kosmo's smart e-cig boasts an LED Smartlight to show progress on the user's daily smoking goal. They are looking to raise 30,000 EUR.

Chrono Therapeutics secures $32 million to further develop its smoking cessation technology

The Series A round was raised from a number of investors, including Canaan Partners, 5AM Ventures, Fountain Healthcare Partners, Mayo Clinic and GE Ventures.